Fisher WE - Search Results

1

Association between somatostatin receptor 5 gene polymorphisms and pancreatic cancer risk and survival.

Li D, Tanaka M, Brunicardi FC, Fisher WE, Gibbs RA, Gingras MC. Li D, et al. Among authors: fisher we. Cancer. 2011 Jul 1;117(13):2863-72. doi: 10.1002/cncr.25858. Epub 2011 Jan 10. Cancer. 2011. PMID: 21692047 Free PMC article.

2

Current progress in suicide gene therapy for cancer.

Yazawa K, Fisher WE, Brunicardi FC. Yazawa K, et al. Among authors: fisher we. World J Surg. 2002 Jul;26(7):783-9. doi: 10.1007/s00268-002-4053-5. Epub 2002 Apr 15. World J Surg. 2002. PMID: 11948367 Review.

3

Laparoscopic pancreatic cystogastrostomy.

Obermeyer RJ, Fisher WE, Salameh JR, Jeyapalan M, Sweeney JF, Brunicardi FC. Obermeyer RJ, et al. Among authors: fisher we. Surg Laparosc Endosc Percutan Tech. 2003 Aug;13(4):250-3. doi: 10.1097/00129689-200308000-00005. Surg Laparosc Endosc Percutan Tech. 2003. PMID: 12960787

4

Somatostatin receptor gene transfer inhibits established pancreatic cancer xenografts.

Celinski SA, Fisher WE, Amaya F, Wu YQ, Yao Q, Youker KA, Li M. Celinski SA, et al. Among authors: fisher we. J Surg Res. 2003 Nov;115(1):41-7. doi: 10.1016/s0022-4804(03)00276-2. J Surg Res. 2003. PMID: 14572771

5

Activation of somatostatin receptor subtype 2 inhibits insulin secretion in the isolated perfused human pancreas.

Brunicardi FC, Atiya A, Moldovan S, Lee TC, Fagan SP, Kleinman RM, Adrian TE, Coy DH, Walsh JH, Fisher WE. Brunicardi FC, et al. Among authors: fisher we. Pancreas. 2003 Nov;27(4):e84-9. doi: 10.1097/00006676-200311000-00019. Pancreas. 2003. PMID: 14576502

6

Specific gene expression and therapy for pancreatic cancer using the cytosine deaminase gene directed by the rat insulin promoter.

Wang XP, Yazawa K, Yang J, Kohn D, Fisher WE, Brunicardi FC. Wang XP, et al. Among authors: fisher we. J Gastrointest Surg. 2004 Jan;8(1):98-108; discussion 106-8. doi: 10.1016/j.gassur.2003.10.008. J Gastrointest Surg. 2004. PMID: 14746841

7

Characterization of somatostatin receptor expression in human pancreatic cancer using real-time RT-PCR.

Li M, Li W, Kim HJ, Yao Q, Chen C, Fisher WE. Li M, et al. Among authors: fisher we. J Surg Res. 2004 Jun 15;119(2):130-7. doi: 10.1016/j.jss.2004.03.006. J Surg Res. 2004. PMID: 15145694

8

Cell-specific cytotoxicity of human pancreatic adenocarcinoma cells using rat insulin promoter thymidine kinase-directed gene therapy.

Tirone TA, Wang XP, Templeton NS, Lee T, Nguyen L, Fisher W, Brunicardi FC. Tirone TA, et al. World J Surg. 2004 Aug;28(8):826-33. doi: 10.1007/s00268-004-7291-x. Epub 2004 Aug 3. World J Surg. 2004. PMID: 15457366

9

Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors.

Li M, Yang H, Chai H, Fisher WE, Wang X, Brunicardi FC, Yao Q, Chen C. Li M, et al. Among authors: fisher we. Cancer. 2004 Nov 15;101(10):2341-50. doi: 10.1002/cncr.20634. Cancer. 2004. PMID: 15476280 Free article.

10

Pancreatic polypeptide administration reduces insulin requirements of artificial pancreas in pancreatectomized dogs.

Kono T, Hanazaki K, Yazawa K, Ashizawa S, Fisher WE, Wang XP, Nosé Y, Brunicardi FC. Kono T, et al. Among authors: fisher we. Artif Organs. 2005 Jan;29(1):83-7. doi: 10.1111/j.1525-1594.2004.29008.x. Artif Organs. 2005. PMID: 15644089

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

191 results

Search Page